Human chromosome 15q11–q13 involves a striking imprinted gene cluster of more than 2 Mb that is concomitant with multiple neurological disorders manifested by Prader–Willi syndrome (PWS) and Angelman syndrome (AS). PWS and AS patients with imprinting mutation have microdeletions, which share a 4.3 kb short region of overlap (SRO) at the 5′ end of the paternal SNURF-SNRPN gene in PWS, or on the maternal allele, which shares a 880 bp SRO located at the 35 kb upstream of the SNURF-SNRPN promoter in AS. Recent studies have revealed an essential role of PWS-SRO in the postzygotic maintenance of the appropriate epigenotype on the paternal chromosome. For AS-SRO, however, there is insufficient experimental evidence exists to determine the direct functions. Here we show that the complete deletion of AS-SRO does not cause any anomalies of imprinted gene expression or DNA methylation on the mutated human chromosome 15, further supporting the idea that AS-SRO is dispensable for post implantation imprint maintenance. This implies that AS-SRO is not essential for the robust epigenotype preservation in somatic cells.
Prader–Willi syndrome (PWS) is characterized by infantile hypotonia, gonadal hypoplasia, obsessive/compulsive behavior, and neonatal feeding difficulties followed by hyperphagia leading to profound obesity. Angelman syndrome (AS) is characterized by severe mental retardation, absent speech, ataxic gait, and a happy demeanor. These distinct neurogenetic disorders are caused by the loss of function of oppositely imprinted genes in human chromosome 15q11–q13 (Jiang et al 1998; Nicholls et al. 1998; Horsthemke et al. 1999; Mann and Bartolomei 1999). PWS is due to a lack of paternal genetic information on human chromosome 15q11–q 13, caused most frequently by a ~4 Mb de novo paternal deletion or maternal uniparental disomy (UPD). By contrast, AS usually results from a lack of maternal 15q11–q13 genetic information, ~4 Mb de novo maternal deletion, or paternal UPD. In addition, mutations in a single gene, UBE3A, which is maternally expressed in specific regions of the brain, occur in some AS patients (Kishino et al. 1997; Matsuura et al. 1997; Rougeulle et al. 1997; Vu and Hoffman 1997). In rare cases of either syndrome, neither parental chromosome displays a gross abnormality, but the maternal chromosome carries a paternal imprint or the paternal chromosome carries a maternal imprint (Buiting et al. 1995; Dittrich et al. 1996; Saitoh et al. 1996). Such patients typically have microdeletions; these imprinting mutations have helped to define an imprinting center (IC) thought to act in cis to regulate the chromatin structure, DNA methylation, and gene expression at 15q11–q 13 (Reis et al. 1994; Sutcliffe et al. 1994; Yang et al. 1998). In PWS imprinting mutations with fully characterized deletion breakpoints, the shortest region of deletion overlap (PWS-SRO) is less than 4.3 kb, spanning the first exon and promoter of SNURF-SNRPN (Buiting et al. 1995; Dittrich et al. 1996; Saitoh et al. 1996). Similarly, the AS-SRO has been narrowed to 880 bp at a site 35 kb upstream of SNRPN, which includes exon U5 of the alternative 5′ SNURF-SNRPN transcripts (Buiting et al. 1995, 1999; Dittrich et al. 1996; Saitoh et al. 1996; Buiting et al. 1999; Farber et al. 1999; Ohta et al. 1999). These observations have led researchers to suggest that the IC is comprised of a bipartite structure that regulates the erasure and reestablishment of parental imprints in the germline. The PWS-SRO and AS-SRO would thus be required for a maternal-to-paternal imprint switch during spermatogenesis or a paternal-to-maternal imprint switch during oogenesis.
Recent data indicate that the maternal imprints on paternal chromosome 15q11–q13 with the PWS-SRO deletion can also be acquired during or after fertilization (Bielinska et al. 2000; Bressler et al. 2001; El-Maarri et al. 2001). As with the PWS-SRO, the role of the AS-SRO must also be considered further. For example, the alternative 5′ SNURF-SNRPN transcripts included in the AS-SRO itself may act in cis to regulate imprinting switching (Dittrich et al. 1996; Farber et al. 1999). Alternatively, trans-acting factors specific to the female germline may interact with the 5′ SNURF-SNRPN transcripts to cause heterochromatin formation (Dittrich et al. 1996; Schweizer et al. 1999; Shemer et al. 2000). Whether or not the AS-SRO element transcripts are conserved in the mouse is as yet unknown; indeed, some observations suggest that human and mouse imprinting mechanisms have diverged (Blaydes et al. 1999). Genetic studies on AS patients with non-IC deletion implicate that some imprinting defects on maternal chromosome 15 are caused by a failure to maintain the imprint postzygotically since, in AS patients, the paternally imprinted maternal chromosome region is inherited from either the maternal grandfather or the maternal grandmother. Moreover, the maternal allele of the SNRPN CpG island displays a paternal methylation pattern in unfertilized human oocytes and biparental complete hydatidiform moles (El-Maarri et al. 2001, 2003). Thus, abnormal methylation on the maternal chromosome is not due to an error in erasing the imprinting marks, but rather abnormal methylation reflects an error in the reprogramming process and/or in the reestablishment or postzygotic maintenance of the new maternal marks. The results suggest that, like the PWS-SRO, the AS-SRO may also influence the postzygotic maintenance of the maternal imprint. To date, there is insufficient evidence to determine if the AS-SRO (including all or a part of AS-SRO) is directly required for postzygotic maintenance of the maternal imprint in human chromosome 15.
To develop an in vitro resource for the investigation of imprinted loci in humans, we have generated a series of monochromosomal cell hybrids that retain single human chromosomes of defined parental origin (Kugoh et al. 1999). This in vitro assay system has led to the identification of multiple transcripts that are differentially expressed from the maternal and paternal chromosomes (Mitsuya et al. 1999; Meguro et al. 2001a, 2001b; Nakabayashi et al. 2002; Yamada et al, 2004). In addition, targeting experiments by using a shuttle system with DT40 cells demonstrates that the human LIT1 locus is required for the somatic maintenance of the paternal epigenotype at the imprinted gene cluster 11p15.5 in somatic cells (Horike et al. 2000). Here we constructed a complete somatic deletion of AS-SRO on human chromosome 15. The expression of imprinted genes and methylation pattern at 15q11–q13 remained completely unchanged in somatic cells lacking AS-SRO, implying that none of the AS-SRO interval is required for imprint maintenance in the soma. Given these observations and the evidence from previous studies implying that AS-SRO may play an essential role in the postzygotic maintenance of the proper epigenotype on the maternal chromosome, potential insights into the etiology of AS are discussed.
Materials and methods
DT40 cells were cultured at 40°C in RPMI1640 medium with 10% fetal calf bovine serum (FCS, Hyclone, Logan, UT, USA), 1% chicken serum, and 50 μM 2-mercaptoethanol (2-ME, Sigma, St. Louis, MO, USA). RPMI medium and chicken serum were obtained from Invitrogen (Carlsbad, CA, USA). Mouse A9 cells containing a paternal or maternal human chromosome 15 tagged with pSV2 bsr or pSV2 neo, respectively, which were used as fusion donors for chromosome transfer, were cultured at 37°C in Dulbecco’s modified Eagle’s medium (DMEM, Sigma) with 10% calf serum (CS, Hyclone) in the presence of 3 μg/ml blasticidin S hydrochloride (BS, Funakoshi, Tokyo, Japan) or 800 μg/ml geneticin (G418, Invitrogen). Chinese hamster CHO cells, which were used as fusion recipients for chromosome transfers, were cultured at 37°C in F-12 nutrient mixture (Invitrogen) with 10% CS.
Microcell-mediated chromosome transfer
Transfer of human chromosome 15 from mouse A9 hybrids to DT40 cells was performed via microcell-mediated chromosome transfer (MMCT), as described previously (Horike et al. 2000) with slight modifications. A9 hybrids (1×108 total) in twelve 25 cm2 flasks were treated with 0.05 μg/ml of colcemid to micronucleate donor cells, which were then purified by digestion with 10 mg/ml of cytochalasin B (Sigma) and centrifugation. The microcell pellets were resuspended in 24 ml of serum-free DMEM, filtered sequentially through 8-, 5-, and 3-μm polycarbonate filters (Whatman, Brentford, Middlesex, UK), and precipitated by centrifugation at 1,800 rpm for 5 min. The purified microcells were then resuspended in 1 ml of serum-free DMEM containing 50 μg/ml of phytohemagglutinin (PHA, BD Biosciences, San Jose, CA, USA). The microcells were attached to 1×107 DT40 cells propagated as an adherent monolayer on the poly-L-lysine-coated wells by centrifugation at 1,500 rpm for 5 min, then the cells were fused within a 50% (w/v) polyethylene glycol 1,500 solution (Roche Diagnostics, Indianapolis, IN, USA) for 1 min. The fusions were diluted in 48 ml medium and divided into a 24-well plate for 24 h. DT40 microcell hybrids were selected in 15 μg/ml BS or 1,500 μg/ml G418 and used as fusion donor cells for subsequent chromosome transfer. CHO microcell hybrids containing a modified human chromosome 15 were obtained by polyethylene glycol-mediated fusion of 5×106 CHO cells with microcells purified by centrifugation from 1×109 DT40 hybrid cells maintained on poly-L-lysine-coated 25 cm2 flasks. The fusions were then selected in 6 μg/ml BS or 800 μg/ml G418, and expanded.
Targeted disruption of the human AS-SRO locus
The targeting was designed to delete the AS-SRO region completely. The 4.2-kb 5′ and 3.5-kb 3′ homologous flanking sequences were subcloned from DNA fragments obtained by PCR amplification of human genomic DNA. The 4.2-kb product was amplified with the oligonucleotide primers 5′-CGGGGTACCCCAAGCCTGGCTAACTTTTG-3′ and 5′-TTCGGGGCCCCAAGCCCCCAGGTGATACTA-3′. The 3.5-kb product was amplified with the primers 5′-CGCGGATCCTGCAGGTGCGTTTTTTTATG-3′ and 5′-AAGGAAAAAAGCGGCCGCCATTTCCAAGAGGGCTGAAG-3′. Stepdown PCR was carried out as follows after incubation at 95°C for 3 min, with annealing temperature being reduced by 2°C every three cycles: 95°C for 45 s, 68°C for 30 s, and 68°C for 4 min. Twenty-six subsequent rounds of PCR were carried out as follows: 95°C for 45 s, 62°C for 30 s, and 68°C for 4 min. KpnI-ApaI and BamHI-NotI digested products were cloned into pBluescript II SK− (Stratagene). Next, the selectable marker pGK puroR cassette was inserted into the KpnI site of the vector. 1×107 DT40 cells containing a paternal or maternal human chromosome 15 were collected in 0.8 ml phosphate-buffered saline and electroporated at 550 V and 25 μF (Gene-Pulser, Bio-Rad, Hercules, CA, USA) with 25 μg targeting vector, which was linearized at the ApaI site. Double-drug selection in 0.5 μg/ml puromycin (Sigma) plus 15 μg/ml BS or 1,500 μg/ml G418 was initiated after 24 h. The correctly targeted DT40 hybrid clones screened by PCR analysis were confirmed by Southern blot analysis using a PCR-generated probe. The amplification primers for the 5′ region-specific probe were 5′-CCTGCTGATTGGTCCATTTT-3′ and 5′-GAAGCCACCTGGACTTCGTA-3′. Those for the 3′ region-specific probe were 5′-TACGGAATCCTAAGGCATGG-3′ and 5′-CAAAGAGCAGCAGCATGGAGGAT-3′.
Conventional chromosome preparations for cytogenetic analysis followed standard procedures to identify a morphologically intact human chromosome 15 in metaphase spreads after chromosome transfer. Chromosomes were stained with Quinacrine plus Hoechst 33258 (Sigma) and the karyotypes of at least 20 well-banded metaphase cells were analyzed. Fluorescence in situ hybridization (FISH) was performed on fixed metaphase spreads of each cell hybrid type using digoxigenin-labeled (Roche Diagnostics) human COT-1 DNA (Invitrogen) and biotin-labeled pGK puroR plasmid DNA, essentially as described (Kugoh et al. 1999). After chromosomes were counterstained with DAPI (Sigma), images were captured via the CytoVision Probe System (Applied Imaging, San Jose, CA, USA), and figures were prepared for reproduction using Adobe Photoshop CS (Adobe Systems, San Jose, CA, USA).
Assessment of allelic expression
Total RNA was extracted using the RNeasy minikit (Qiagen, Valencia, CA, USA) and treated with RNase-free DNase I (Nippon Gene, Toyama, Japan) to remove contaminating DNA. First-strand cDNA synthesis was carried out with an oligo(dT)15 primer (Roche Diagnostics) and M-MLV reverse transcriptase (Invitrogen). PCR was performed with AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA) using a stepdown protocol, as described previously (Meguro et al. 2001a). Reaction products were analyzed by electrophoresis in a 2.0% agarose gel and stained with SYBR Green I (Molecular Probes, Eugene, OR, USA). Primer sequences used to detect parental-allele-specific expression on 15q11–q13 are available upon request.
The DNA methylation state of the SNRPN CpG island was examined by Southern blot, as described previously (Meguro et al. 1997). Genomic DNA was extracted by standard phenol-chloroform extraction methods, and 5 μg of genomic DNA was digested with the appropriate restriction enzymes. The resulting fragments were separated on a 0.8% agarose gel. The 4.2-kb XbaI fragment labeled with [α−32 P]dCTP was used as a probe for the SNRPN CpG island, and the DNA blots were imaged with a BAS-2500 bioimaging analyzer (Fuji Film, Tokyo, Japan).
Targeted deletion of the AS-SRO on maternal and paternal human chromosome 15
We used gene targeting to delete the AS-SRO region on human chromosome 15 in recombination-proficient DT40 cells. We had previously established monochromosomal hybrids that contain a maternal (hChr15M) or paternal (hChr15P) human chromosome 15 tagged with the pGK neo or pSV2 bsr, respectively (Kugoh et al. 1999). In this study, the tagged hChr15M and hChr15P independently transferred from these cell hybrids into recombination-proficient DT40 cells using MMCT. Two to 3 weeks after fusion, we isolated 12 G418-resistant clones that contained hChr15M and 27 BS-resistant clones that contained hChr15P. The presence of human chromosome 15 sequences in each of these hybrid clones was confirmed by PCR using the sequence-tagged site markers WI15852 (P-locus) and SGC35648 (ZNF127) on 15q11–q13. Twelve clones of each type were analyzed for the presence of intact human chromosome 15 by double staining with Quinacrine plus Hoechst 33258. All clones but one were found to contain a single, intact copy of hChr15M or hChr15P and were chosen for further analysis.
For exact deletion of AS-SRO, we constructed a targeting construct in which the 880-bp of AS-SRO was replaced by the pGK puroR cassette. This vector was introduced into the DT40 hybrid clones with a hChr15M or hChr15P by electroporation. Thirty puror /G418r clones, designated DT40(15MΔAS-SRO), and 18 puror /BSr clones, designated as DT40 (15PΔAS-SRO), were obtained from DT40 cell donors that retained intact single human chromosomes (Fig. 1a). Next, attempts were made to separate random insertion from homologous recombinants. Drug-resistant DT40 clones were initially screened by PCR for the presence of the AS-SRO or the puromycin-resistance gene. The PCR screening identified seven hChr15M and six hChr15P that were potentially correctly targeted (data not shown). Genomic DNA from four clones of each type was then analyzed by Southern blotting. If there was homologous recombination, the 5′ probe would detect a 6.1-kb EcoT22I fragment whereas random insertions would yield a wild-type 7.2-kb fragment and additional fragments of unspecified size. Targeted clones were also checked at the 3′ end, where a >10-kb ApaI fragment in wild-type DT40 cells is converted to a 5.7-kb fragment in targeted clones (data not shown). Three hChr15M and two hChr15P homologous recombinants were obtained (Fig. 1b). FISH with a probe derived from the plasmid pGK puroR confirmed that the targeting construct integrated at the assigned site of the 15q11–q13 region (Fig. 2).
Expression and methylation-state analysis on 15q11–q13
To assess the function of the targeted alleles, we transferred correctly modified human chromosomes hChr15MΔAS-SRO and hChr15PΔAS-SRO as well as normal intact human chromosomes hChr15M and hChr15P into CHO cells via MMCT. After fusion and selection, we obtained 25 cell hybrids containing hChr15MΔAS-SRO, 32 with hChr15PΔAS-SRO, 29 with hChr15M, and 27 with hChr15P. Five clones of each were characterized by PCR and FISH (Fig. 2, and data not shown) and used for further studies on expression and DNA methylation studies. To test whether targeted deletion of AS-SRO affects the imprinting status of the imprinted domain, RT-PCR analysis was performed on RNA from cell hybrids that contained either hChr15PΔAS-SRO or hChr15MΔAS-SRO as well as from control cell hybrids that contained hChr15P or hChr15M. We examined the allelic expression profiles of multiple oppositely imprinted genes: NDN, SNRPN, UBE3A, and ATP10C. IPW was also included to assess the allelic expression of small nucleolar RNAs (snoRNAs), both of which can be transcribed from the same promoter. NDN, SNRPN and IPW, which are paternally expressed genes, were expressed from only clones that contain hChr15PΔAS-SRO or hChr15P (Fig. 3). UBE3A and ATP10C are imprinted with preferential maternal expression in the brain but are biallelically expressed in other tissues (Rougeulle et al. 1997; Vu and Hoffman 1997; Herzing et al. 2001; Meguro et al. 2001b). Consistent with this, UBE3A and ATP10C were equally transcribed from both paternal and maternal chromosomes. Biallelic expression was also evident in cells with mutated chromosomes. These results clearly indicate that the AS-SRO deletion has no significant effect on the expression of imprinted genes on human chromosome 15.
To assess the epigenetic modifications on the modified chromosomes, DNA methylation studies of the SNRPN CpG island were subsequently performed by Southern blot hybridization. Genomic DNA was digested with XbaI and the methylation-sensitive restriction enzyme NotI, and probed with a SNRPN exon 1 DNA fragment in order to detect the expected 3.0- and 0.9-kb signals (unmethylated DNA) or the 4.2-kb signal (methylated DNA). The unmethylated 3.0- and 0.9-kb and the methylated 4.2-kb signals were observed in cultured normal human fibroblasts consistent with the expected maternal methylation of the SNRPN CpG island. In cell hybrids containing the single hChr15M, only the methylated 4.2-kb band was detected. These results demonstrate that the maternal methylation at the SNRPN CpG island was retained appropriately in the somatic cell cultures. Similarly, the SNRPN CpG island was unmethylated on the mutated paternal chromosome and was methylated in the maternal one. Expression and DNA methylation studies on at least five individual clones gave the same results. Together, these data show that the complete AS-SRO deletion exerted no detectable impairments with respect to imprint preservation in the 15q11–q13 imprinted domain.
To explore whether deletion of the AS-SRO affects the maintenance of imprinting in cis at the 15q11–q13 imprinted domain, we generated modified human chromosomes that carry a targeted deletion of AS-SRO using recombination-proficient DT40 cells. A substantial number of studies on both PWS-SRO knockout mouse models and PWS-SRO deletion in PWS patients have advanced our understanding of PWS-SRO functions in the soma. Recently, Bielinska et al. (2000) showed that deletion of the SNURF-SNRPN exon 1 region on the paternal chromosome of early human and mouse embryos causes somatic switching from a paternal to a maternal epigenotype. The data suggest that PWS-SRO is required for the postzygotic maintenance of the paternal imprint. Furthermore, El-Maarri et al. (2001) demonstrated that sperm DNA from males with a maternally inherited deletion of the PWS-SRO have a normal paternal imprint. Together, these observations indicate that the maternal imprints on paternal chromosome 15q11–q13 with PWS-SRO deletion can also be acquired during or after fertilization. In contrast, the role of AS-SRO has historically been poorly understood. Use of mice as a model for AS-SRO function is closed by the fact that it is still unclear if the AS-SRO element is present in mice. To date, how we think about the AS-SRO is largely based on inferences drawn from the studies from AS patients. This includes the idea that the paternal methylation pattern on maternal chromosome 15 might be due to an error in the reestablishment or the postzygotic maintenance of the maternal methylation pattern (El-Maarri et al. 2001, 2003). Another interpretation of the findings is that AS-SRO may be correlated with the postzygotic maintenance of the parent’s origin imprint, as is the case for PWS-SRO.
To define the role of the AS-SRO, we tested the expression of multiple imprinted genes and analyzed DNA methylation at the SNRPN CpG island within 15q11–q13 in cells retaining a human chromosome 15 lacking the AS-SRO. In AS patients with an imprinting mutation, paternally expressed genes (SNRPN, NDN, IPW, and others) at 15q11–q13 are transcribed from the mutated maternal allele, which lacks the maternal methylation at the SNRPN CpG island. In this study, we found that complete deletion of the AS-SRO does not cause the paternally expressed genes to be expressed from maternal alleles, and furthermore, that the SNRPN CpG island within PWS-SRO remains methylated on the modified maternal allele. These findings demonstrate that there are no significant alterations in the imprinting state of the PWS/AS chromosomal domain on the modified maternal or paternal human chromosomes lacking the AS-SRO. This suggests that AS-SRO itself and/or AS-SRO binding protein(s) may be necessary to acquire the maternal imprint at this imprinted domain but not to preserve the parental epigenotype in the soma. This contrasts with our previous observation that targeted deletion of the KvDMR1 imprinting center led to bidirectional activation of the multiple maternally expressed transcripts on the paternal chromosome in somatic cells. Indeed, our findings further support the idea that the AS-SRO might have a role in the establishment of the maternal DNA methylation at PWS-SRO (Kelsey and Reik 1997; Perk et al. 2002; Kantor et al. 2004a, 2004b) using a 1.0-kb minitransgene consisting of AS-SRO and the 160-bp murine SNRPN minimal promoter, suggested that AS-SRO is essential for the establishment of the differential imprint state on parental alleles. Therefore, we would propose that in AS patients with an imprinting mutation, the maternal chromosome 15 results from a defect in establishment, not maintenance, of the maternal epigenotype.
What, then, is the role of the AS-SRO in resetting the maternal imprint in the germ line? Upstream exons of SNURF-SNRPN were identified, and there is evidence of alternative splicing and promoter usage (Dittrich et al. 1996; Farber et al. 1999). The AS-SRO includes exon U5 of the 5′ transcript. It may be argued that the deletion of U5 is irrelevant (e.g., because several splice variants lack U5). However, we would argue that this transcript could be associated with epigenotype switching since we detected several splice variants that lack U5 (data not shown). Alternatively, the AS-SRO may contain a binding site for a trans-acting factor required for the paternal-to-maternal imprint switch (Dittrich et al. 1996; Schweizer et al. 1999; Shemer et al. 2000). This trans-acting factor may bind the AS-SRO during oogenesis or during early embryogenesis and interact in cis with the PWS-SRO, leading to establishment of the maternal imprint. Further analysis will be required to determine the role of any trans-acting factors that participate in the switch mechanism.
The chicken pre-B cell line, DT40, is capable of homologous recombination between exogenous DNA templates and targeted regions with an efficiency of 10–100% (Buerstedde and Takeda 1991). In this study, homologous recombination events that remove the AS-SRO were obtained at a substantial and reproducible frequency of >1 in six puromycin-resistant clones, which is consistent with our previous results (Horike et al. 2000). It has been reported that the genes on human chromosome transferred into DT40 cells can also be targeted by homologous recombination and that the modified human chromosomes can then be transferred back into mammalian cells for functional assays. Transfer of human chromosomes to DT40 cells does not appear to irreversibly alter the expression of genes on those chromosomes (Kuroiwa et al. 2002; Ishida et al. 2002). Thus, changes in expression, DNA methylation state, chromatin structure, replication timing, or other parameters can be attributed to the effects of introduced mutations. In addition, we previously reported use of the DT40 cell shuttle system to show that the human LIT1 locus can act as a negative regulator in cis for coordinating local control of imprinting on chromosome 11p15.5 (Horike et al. 2000). In this context, it is interesting to note that this imprinting center may possess a unidirectional chromatin insulator (Kanduri et al. 2002). Here we performed the expression and DNA methylation analyses at 15q11–q13 in cell hybrids in which the imprinting status on human chromosome 15 was maintained, as evidenced by the proper, cell-type-specific regulation of human genes on the transferred chromosomes (Figs. 3, 4). Furthermore, our results suggest that the AS-SRO might be necessary to acquire the maternal imprint but not to maintain the imprinted state on human chromosome 15q11–q13 in somatic cells.
Single human chromosomes retained in CHO hybrids can be introduced via MMCT into any other cells including mouse embryonic stem (ES) cells via MMCT. It was recently suggested, based on a cell culture model of neurogenesis, that Ube3a antisense transcripts contain upstream exons and that multiple alternatively spliced Ube3a antisense transcripts regulate brain-specific silencing of Ube3a (Rougeulle et al. 1998; Chamberlain and Brannan 2001; Yamasaki et al. 2003; Landers et al. 2004). This possibility can be investigated for human chromosomes 15 using the DT40 cell shuttle system and a cell culture model of neurogenesis. Furthermore, it has also recently been reported that assisted reproductive technology (ART), including both in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), could lead to epigenetic defects such as large offspring syndrome (LOS), which is mainly seen in ruminants (Niemitz and Feinberg 2004). There is evidence that ART might cause Beckwith–Wiedemann syndrome, retinoblastoma, and AS (Cox et al. 2002; DeBaun et al. 2003; Maher et al. 2003; Moll et al. 2003; Orstavik et al. 2003), perhaps because of embryo culture itself or the media used although there might be other possibilities. In this context, our findings clearly indicate that the robust parental epigenotype at 15q11–q13 can be maintained in somatic cells even if the critical interval is disrupted. In PWS patients with imprinting mutations, it is suggested that the PWS/AS imprinting center may be required to preserve the parental epigenotype on the paternal chromosome during early embryogenesis when the process of global demethylation and de novo methylation takes place (Bielinska et al. 2000; Mann and Bartolomei 2000). In fact, deletion of the imprinting center does not interfere with DNA methylation alterations in ES cell cultures. To address these issues, it would be critical to ascertain the consequences of the defined deletion of AS-SRO using mouse models containing the modified human chromosome used in this study. Thus, our DT40 cell shuttle system should permit a rapid and exclusive dissection of the epigenetic properties of imprinting centers.
Bielinska B, Blaydes SM, Buiting K, Yang T, Krajewska-Walasek M, Horsthemke B, Brannan CI (2000) De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch. Nat Genet 25:74–78
Blaydes SM, Elmore M, Yang T, Brannan CI (1999) Analysis of murine Snrpn and human SNRPN gene imprinting in transgenic mice. Mamm Genome 10:549–555
Bressler J, Tsai TF, Wu MY, Tsai SF, Ramirez MA, Armstrong D, Beaudet AL (2001) The SNRPN promoter is not required for genomic imprinting of the Prader–Willi/Angelman domain in mice. Nat Genet 28:232–240
Buerstedde JM, Takeda S (1991) Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67:179–188
Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S. Nicholls RD, Horsthemke B (1995) Inherited microdeletions in the Angelman and Prader–Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet 9:395–400
Buiting K, Lich C, Cottrell S, Barnicoat A, Horsthemke B (1999) A 5 kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Hum Genet 105, 665–666
Chamberlain SJ, Brannan CI (2001) The Prader–Willi syndrome imprinting center activates the paternally expressed murine Ube3a antisense transcript but represses paternal Ube3a. Genomics 73:316–322
Cox GF, Burger J, Lip V, Mau UA, Sperling K, Wu BL, Horsthemke B (2002) Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet 71:162–164
DeBaun MR, Niemitz EL, Feinberg AP (2003) Association of in vitro fertilization with Beckwith–Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 72:156–160
Dittrich B, Buiting K, Korn B, Rickard S, Buxton J, Saitoh S, Nicholls RD, Poustkam A, Winterpacht A, Zabel B, Horsthemke B (1996) Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet 14:163–170
El-Maarri O, Buiting K, Peery EG, Kroisel PM, Balaban B, Wagner K, Urman B, Heyd J, Lich C, Brannan CI, Walter J, Horsthemke B (2001) Maternal methylation imprints on human chromosome 15 are established during or after fertilization. Nat Genet 27:341–344
El-Maarri O, Seoud M, Coullin P, Herbiniaux U, Oldenburg J, Rouleau G, Slim R (2003) Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles. Hum Mol Genet 12:1405–1413
Farber C, Dittrich B, Buiting K, Horsthemke B (1999) The chromosome 15 imprinting centre (IC) region has undergone multiple duplication events and contains an upstream exon of SNRPN that is deleted in all Angelman syndrome patients with an IC microdeletion. Hum Mol Genet 8:337–343
Herzing LB, Kim SJ, Cook EH Jr, Ledbetter DH (2001) The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression. Am J Hum Genet 68:1501–1505
Horike S, Mitsuya K, Meguro M, Kotobuki N, Kashiwagi A, Notsu T, Schulz TC, Shirayoshi Y, Oshimura M (2000) Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith–Wiedemann syndrome. Hum Mol Genet 14:2075–2083
Horsthemke B, Surani A, James T, Ohlsson R (1999) The mechanisms of genomic imprinting. Results Probl Cell Differ 25:91–118
Ishida I, Tomizuka K, Yoshida H, Kuroiwa Y (2002) TransChromo Mouse. Biotechnol Genet Eng Rev 19:73–82
Jiang Y, Tsai TF, Bressler J, Beaudet AL (1998) Imprinting in Angelman and Prader–Willi syndromes. Curr Opin Genet Dev 8:334–342
Kanduri C, Fitzpatrick G, Mukhopadhyay R, Kanduri M, Lobanenkov V, Higgins M, Ohlsson R (2002) A differentially methylated imprinting control region within the Kcnq1 locus harbors a methylation-sensitive chromatin insulator. J Biol Chem 277:18106–18110
Kantor B, Makedonski K, Green-Finberg Y, Shemer R, Razin A (2004a) Control elements within the PWS/AS imprinting box and their function in the imprinting process. Hum Mol Genet 13:751–762
Kantor B, Kaufman Y, Makedonski K, Razin A, Shemer R (2004b) Establishing the epigenetic status of the Prader–Willi/Angelman imprinting center in the gametes and embryo. Hum Mol Genet 13:2767–2779
Kelsey G, Reik W (1997) Imprint switch mechanism indicated by mutations in Prader–Willi and Angelman syndromes. Bioessays 19:361–365
Kishino T, Lalande M, Wagstaff J (1997) UBE3A E6-AP mutations cause Angelman syndrome. Nat Genet 15:70–73
Kugoh H, Mitsuya K, Meguro M, Shigenami K, Schulz T C, Oshimura M (1999) Mouse A9 cells containing single human chromosomes for analysis of genomic imprinting. DNA Res 6:165–172
Kuroiwa Y, Kasinathan P, Choi YJ, Naeem R, Tomizuka K, Sullivan EJ, Knott G, Duteau A, Goldsby RA, Osborne BA, Ishida I, Robl JM (2002) Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol 20:889–894
Landers M, Bancescu DL, Le Meur E, Rougeulle C, Glatt-Deeley H, Brannan C, Muscatelli F, Lalande M (2004) Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of SnurfSnrpn. Nucleic Acids Res 32:3480–3492
Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, Cole TR, Macdonald F, Sampson JR, Barratt CL, Reik W, Hawkins MM (2003) Beckwith–Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet 40:62–64
Mann MR, Bartolomei MS (1999) Towards a molecular understanding of Prader–Willi and Angelman syndromes. Hum Mol Genet 8:1867–1873
Mann MR, Bartolomei MS (2000) Maintaining imprinting. Nat Genet 25:4–5
Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, Rommens JM, Beaudet AL (1997) De novo truncating mutations in E6-AP ubiquitin–protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15:74–77
Meguro M, Mitsuya K, Sui H, Shigenami K, Kugoh H, Nakao M, Oshimura M (1997) Evidnce for uniparental paternal expression of the human GABAA receptor subunit genes using microcell-mediated chromosome transfer. Hum Mol Genet 6:2127–2133
Meguro M, Mitsuya K, Nomura N, Kohda M, Kashiwagi A, Nishigaki R, Yoshioka H, Nakao M, Oishi M, Oshimura M (2001a) Large-scale evaluation of imprinting status in the Prader–Willi syndrome region: an imprinted direct repeat cluster resembling small nucleolar RNA genes. Hum Mol Genet 10:383–394
Meguro M, Kashiwagi A, Mitsuya K, Nakao M, Kondo I, Saitoh S, Oshimura M (2001b) A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome. Nat Genet 28:19–20
Mitsuya K, Meguro M, Lee MP, Katoh M, Schulz TC, Kugoh H, Yoshida MA, Niikawa N, Feinberg AP, Oshimura M (1999) LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet 8:1209–1217
Moll AC, Imhof SM, Cruysberg JR, Schouten-van Meeteren AY, Boers M, van Leeuwen FE (2003) Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet 361:309–310
Nakabayashi K, Bentley L, Hitchins MP, Mitsuya K, Meguro M, Minagawa S, Bamforth JS, Stanier P, Preece M, Weksberg R, Oshimura M, Moore GE, Scherer SW (2002) Identification and characterization of an imprinted antisense RNA (MESTIT1) in the human MEST locus on chromosome 7q32. Hum Mol Genet 11:1743–1756
Nicholls RD, Saitoh S, Horsthemke B (1998) Imprinting in Prader–Willi and Angelman syndromes. Trends Genet 14:194–200
Niemitz EL, Feinberg AP (2004) Epigenetics and assisted reproductive technology: a call for investigation. Am J Hum Genet 74:599–609
Ohta T, Buiting K, Kokkonen H, McCandless S, Heeger S, Leisti H, Driscoll DJ, Cassidy SB, Horsthemke B, Nicholls RD (1999) Molecular mechanism of Angelman syndrome in two large families involves an imprinting mutation. Am J Hum Genet 64:385–396
Orstavik KH, Eiklid K, van der Hagen CB, Spetalen S, Kierulf K, Skjeldal O, Buiting K (2003) Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet 72:218–219
Perk J, Makedonski K, Lande L, Cedar H, Razin A, Shemer R (2002) The imprinting mechanism of the Prader–Willi/Angelman regional control center. EMBO J 21:5807–5814
Reis A, Dittrich B, Greger V, Buiting K, Lalande M, Gillessen-Kaesbach G, Anvret M, Horsthemke B (1994) Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader–Willi syndromes. Am J Hum Genet 54:741–747
Rougeulle C, Glatt H, Lalande M (1997) The Angelman syndrome candidate gene, UBE3AE6-AP, is imprinted in brain. Nat Genet 17:14–15
Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M (1998) An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet 19:15–16
Saitoh S, Buiting K, Rogan PK, Buxton JL, Driscoll DJ. Arnemann J, Konig R, Malcolm S, Horsthemke B, Nicholls RD (1996) Minimal definition of the imprinting center and fixation of chromosome 15q11–q13 epigenotype by imprinting mutations. Proc Natl Acad Sci USA 93:7811–7815
Schweizer J, Zynger D, Francke U (1999) In vivo nuclease hypersensitivity studies reveal multiple sites of parental origin-dependent differential chromatin conformation in the 150 kb SNRPN transcription unit. Hum Mol Genet 8:555–566
Shemer R, Hershko AY, Perk J, Mostoslavsky R, Tsuberi B, Cedar H, Buiting K, Razin A (2000) The imprinting box of the Prader–Willi/Angelman syndrome domain. Nature Genet 26:440–443
Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, Ledbetter DH, Beaudet AL (1994) Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet 8:52–58
Vu TH, Hoffman AR (1997) Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet 17:12–13
Yamada T, Mitsuya K, Kayashima T, Yamasaki K, Ohta T, Yoshiura K, Matsumoto N, Yamada H, Minakami H, Oshimura M, Niikawa N, Kishino T (2004) Imprinting analysis of 10 genes and/or transcripts in a 1.5 Mb MEST-flanking region at human chromosome 7q32. Genomics 83:402–412
Yamasaki K, Joh K, Ohta T, Masuzaki H, Ishimaru T, Mukai T, Niikawa N, Ogawa M, Wagstaff J, Kishino T (2003) Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet 12:837–847
Yang T, Adamson TE, Resnick JL, Leff S, Wevrick R, Francke U, Jenkins NA, Copeland NG, Brannan CI (1998) A mouse model for Prader–Willi syndrome imprinting-centre mutations. Nat Genet 19:25–31
We thank Mitsuyoshi Nakao for the probe used for methylation analysis. This study was supported in part by a Health and Labor Sciences Research Grant for Research on Human Genome Tissue Engineering from the Ministry of Health, Labor and Welfare, Japan. The work also was partly supported by the 21st century COE program, “ The Research Core for Chromosome Engineering Technology.”
About this article
Cite this article
Haruta, M., Meguro, M., Sakamoto, Yk. et al. Narrowed abrogation of the Angelman syndrome critical interval on human chromosome 15 does not interfere with epigenotype maintenance in somatic cells. J Hum Genet 50, 124–132 (2005). https://doi.org/10.1007/s10038-005-0231-2
- Genomic imprinting
- DT40 cell shuttle system
- Imprinting center
- DNA methylation